title: Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology.
abstract: Amiodarone has become an important drug for the treatment of supraventricular and ventricular arrhythmias, in short-term inpatient and outpatient settings. It may also have a role in affecting outcome in patients at high risk for arrhythmic events and sudden death; its place among available therapies is being established in clinical trials.
authors.affiliation: Cardiology Division, University of California, San Francisco, San Francisco General Hospital, 94110, USA.
authors.forename: N
authors.initials: N
authors.lastname: Goldschlager
authors.forename: A E
authors.initials: AE
authors.lastname: Epstein
authors.forename: G
authors.initials: G
authors.lastname: Naccarelli
authors.forename: B
authors.initials: B
authors.lastname: Olshansky
authors.forename: B
authors.initials: B
authors.lastname: Singh
mesh_terms: D000284:Administration, Oral; D000638:Amiodarone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D004347:Drug Interactions; D006801:Humans; D007262:Infusions, Intravenous; D016032:Randomized Controlled Trials as Topic
chemical_list: D000889:Anti-Arrhythmia Agents; D000638:Amiodarone